These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 14664793)

  • 1. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain.
    Fu H; Muenzer J; Samulski RJ; Breese G; Sifford J; Zeng X; McCarty DM
    Mol Ther; 2003 Dec; 8(6):911-7. PubMed ID: 14664793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
    Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
    Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion.
    Burger C; Nguyen FN; Deng J; Mandel RJ
    Mol Ther; 2005 Feb; 11(2):327-31. PubMed ID: 15668145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses.
    Jayandharan GR; Zhong L; Sack BK; Rivers AE; Li M; Li B; Herzog RW; Srivastava A
    Hum Gene Ther; 2010 Mar; 21(3):271-83. PubMed ID: 19788390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice.
    Gholizadeh S; Tharmalingam S; Macaldaz ME; Hampson DR
    Hum Gene Ther Methods; 2013 Aug; 24(4):205-13. PubMed ID: 23808551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
    Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No tumour-initiating risk associated with scAAV transduction in newborn rat liver.
    Gauttier V; Pichard V; Aubert D; Kaeppel C; Schmidt M; Ferry N; Conchon S
    Gene Ther; 2013 Jul; 20(7):779-84. PubMed ID: 23364314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors.
    Miyake N; Miyake K; Yamamoto M; Hirai Y; Shimada T
    Brain Res; 2011 May; 1389():19-26. PubMed ID: 21397590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice.
    McCarty DM; DiRosario J; Gulaid K; Muenzer J; Fu H
    Gene Ther; 2009 Nov; 16(11):1340-52. PubMed ID: 19587708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo.
    Ren C; Kumar S; Shaw DR; Ponnazhagan S
    Hum Gene Ther; 2005 Sep; 16(9):1047-57. PubMed ID: 16149903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters.
    Bockstael O; Chtarto A; Wakkinen J; Yang X; Melas C; Levivier M; Brotchi J; Tenenbaum L
    Hum Gene Ther; 2008 Nov; 19(11):1293-305. PubMed ID: 19866492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular gene transfer with self-complementary AAV vectors.
    Yokoi K; Kachi S; Zhang HS; Gregory PD; Spratt SK; Samulski RJ; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3324-8. PubMed ID: 17591905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient retrograde neuronal transduction utilizing self-complementary AAV1.
    Hollis ER; Kadoya K; Hirsch M; Samulski RJ; Tuszynski MH
    Mol Ther; 2008 Feb; 16(2):296-301. PubMed ID: 18223548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
    Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
    Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosome-associated AAV vector as a robust and convenient neuroscience tool.
    Hudry E; Martin C; Gandhi S; György B; Scheffer DI; Mu D; Merkel SF; Mingozzi F; Fitzpatrick Z; Dimant H; Masek M; Ragan T; Tan S; Brisson AR; Ramirez SH; Hyman BT; Maguire CA
    Gene Ther; 2016 Apr; 23(4):380-92. PubMed ID: 26836117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing transduction of the liver by adeno-associated viral vectors.
    Nathwani AC; Cochrane M; McIntosh J; Ng CY; Zhou J; Gray JT; Davidoff AM
    Gene Ther; 2009 Jan; 16(1):60-9. PubMed ID: 18701909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular injection of adeno-associated virus 6 and 9 vectors for cell type-specific transgene expression in the spinal cord.
    Dirren E; Towne CL; Setola V; Redmond DE; Schneider BL; Aebischer P
    Hum Gene Ther; 2014 Feb; 25(2):109-20. PubMed ID: 24191919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.